Process Research & DevelopmentHighly trained and experienced ARCINOVA chemists can support all aspects of drug substance development. Typically, we work with clients to select and develop optimum synthetic routes for drug substance manufacture, with a view to process economy, product purity, process scalability and safety. The drug substance can be scaled to multi-kg production volumes to support direct client supply, or as part of an integrated drug substance / drug product integrated package where the supply of both in house developed drug substance and drug product can be carefully managed.
Bio2Business 2018Bio2Business Basel 2018 will be attended by Nathalie Huther, Business Development Manager Europe.
Bio2Business 2018Dates: 19th - 20th JuneLocation: Basel, Switzerland
ChemSpec EuropeThe ChemSpec Europe Conference will be attended by Gareth Jenkins, Chief Scientific Officer at Arcinova. Gareth has been invited to chair 'Sessions 3 and 5' for the Royal Society of Chemistry's Special Symposium, during the two-day event.
ChemSpec EuropeDates: 20th - 21st June 2018Location: Cologne, Germany
Scale-up of Chemical Processes ConferenceThe Scale-up of Chemical Processes Conference will be attended by Nathalie Huther, Business Development Manager Europe.
Scale-up of Chemical Processes ConferenceDates: 25th - 27th JuneLocation: Prague